The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
The company state that they have £300M in contracts out for consideration. If the customer doesn’t like the offering, where else are they going to go?
Also, the customer can read the RNS’s just as we can. The price of performing the contract is surely no surprise to them! They wouldn’t have come to the table unless they expected to pay through the nose.
Let’s hope one or two land soon.
Very interesting that Jigger_1.
Over that period the Market Cap rose by 59.4M. The value of contracts was 15.2M. That represents £3.9M increase in market cap for each Million announced in a contract.......or about 65p on the share!
I've clearly got too much time on my hands ??
That’s my target too. I don’t think a market cap of £350m to £400m is unreasonable for a company that is at the forefront of human challenge, is in a market it entirely dominates and who appear to be conquering the Asia Pacific region.
Think you may have the wrong poster. I seem to recall it was your good self that was calling it a ponzi scheme in December.
I may have criticised CF and I stand by those comments. Otherwise I have been in this stock for 18 months and have not sold a single share.
I think you are a bit of an oddball, but I forgive you.
Cheers
Revenues do not = profits.
Of course you are right, but conversely, you cant have profits without revenue and the order book here is strong.
This period is about establishing the business and gaining market share, much like Orange did in the 90’s (they didn’t make a profit for over 10 years).
I accept that the share price won’t rise until we see sizeable and sustained profits, but give the business a chance, we are still a very young business.
I came across OO a couple of years back and thought it was is the right space at the right time. Coincidentally, I had held Fastnet shares in the past where CF was Chairman. I attended a Fastnet investor meet where he presented. This was during a drilling operation in Morocco. He absolutely indicated that the drill had been successful, when later it was determined it was a duster. Many at the meet invested in the basis of what he said.
More fool me for investing here you could say. That said, the guy does not have day to day involvement in the business and has handed the reigns (it appears) to someone more competent.
I think however we are living with CF’s legacy. He is not considered trustworthy and this was echoed at another Amryt presentation I attended shortly after he moved on from there. He is always looking for something else (an admission he made himself), and this coupled with his ‘quick win’ mindset does nothing for stability.
So, am I missing something here:
1. Razza is saying that covid is not really a problem (he’s provided good links);
2. Flu is more of an issue;
3. Current Challenge Studies are not based on Covid (nor will they be);
4. We have a flu vaccine potential (with SEEK (49%);
5. We are doing Challenge Studies regardless of the above…..
Years ago (25+) I held two shares; Pacific Media (PCM) and Tadpole Technolgy (TAD). I used to subscribe to a site called MarketEye. That site was the first of the bulletin board sites I believe. There were two posters (Shed - PCM, and KFM2 - TAD). Anyone that disagreed with these tow tw&ts were immediately pounced on by their followers (or other ill informed tw&ts). Yet many just asked genuine questions. Both shares are gone now. Mostly everyone lost (me included - about £30k overall). Point is, no information should be relied on, on any BB. Everyone is faceless and everyone has an agenda. As soon as some poster starts to insult another poster, there is an agenda!
There is no AIM corruption here, it's a combination of (in order):
1. CF Bullsh*t (damaging) legacy
2. Very low margin business (albeit niche for now)
3. Market (PIs) not understanding the potential?
4. II's not understanding the potential
5. Low market cap precluding certain II's.
6. Very low stock liquidity based on the above...
In relation to point 1., he distanced himself from Fastnet O&G and Amryt Pharma having given both companies his special kind of 'blarney' along the way (I was there!) and investors were left out in the cold (as good as bust in relation to Fastnet).
Forgetting the corruption argument, if it was a great business, someone would buy it at this price. They are not! It's £60M to buy (potentially).... peanuts for a company that has just paid 13M for one study!
Why are there no buyers?
1. Liability (maybe?)
2. Debt (sure there isn't any?!)
3. Scalability?
4. Intellectual property conflict?
5. Association (CF and AIM)?
Not sure....
Comments welcome......
The guy is worth over £100M.
I found it very underwhelming, but don’t ask me why! I just wasn’t very excited by anything that was said. Slow and steady….
There was no new information that I heard, but happy to be enlightened.
Anyway, I am not selling as conversely, there was nothing said that would convince me selling would be a good idea…